Clinuvel Pharmaceuticals Financials - Benzinga

Clinuvel Pharmaceuticals Ltd

CUVLNASDAQ

Trade with Public

Trade with Public

$6.20

-0.04-0.64%

At close: Sep 2, 5:00 PM EST

$6.22

0.020.32%

After Hours: 9:29 AM EST

Overview NewsFinancialsSentiment Compare Stock Report

Clinuvel Pharmaceuticals Financials

Clinuvel Pharmaceuticals (CUVL) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
CLINUVEL FY2026 Revenue Dips 1% To $94.0M From $95.0M, Cash Reserves Rise 12% To $252.1M Amid US Expansion Push

"CLINUVEL’s cash reserves following a decade of profitable operations give us financial independence in a period that has been challenging for many life science companies," said Mr Peter Vaughan, CLINUVEL’s

Benzinga Newsdesk